NY S03400 | 2023-2024 | General Assembly
Status
Spectrum: Moderate Partisan Bill (Democrat 12-2)
Status: Introduced on January 31 2023 - 25% progression
Action: 2024-06-03 - PRINT NUMBER 3400A
Pending: Senate Finance Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on January 31 2023 - 25% progression
Action: 2024-06-03 - PRINT NUMBER 3400A
Pending: Senate Finance Committee
Text: Latest bill text (Amended) [HTML]
Summary
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Title
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Sponsors
Roll Calls
2024-02-13 - Senate - Senate Health Committee Vote (Y: 14 N: 1 NV: 0 Abs: 0) [PASS]
2023-05-17 - Senate - Senate Health Committee Vote (Y: 14 N: 1 NV: 0 Abs: 0) [PASS]
2023-05-17 - Senate - Senate Health Committee Vote (Y: 14 N: 1 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-06-03 | Senate | PRINT NUMBER 3400A |
2024-06-03 | Senate | AMEND (T) AND RECOMMIT TO FINANCE |
2024-02-13 | Senate | REPORTED AND COMMITTED TO FINANCE |
2024-01-03 | Senate | REFERRED TO HEALTH |
2023-05-17 | Senate | REPORTED AND COMMITTED TO FINANCE |
2023-01-31 | Senate | REFERRED TO HEALTH |
Same As/Similar To
A07268 (Same As) 2024-05-22 - reported referred to rules